Valuation: Medtide Inc.

Market Cap 2.85B 3.3B 421M 369M 341M 314M 592M 40.63B 602M 4.08B 1.6B 19.88B 1.58B 1.55B 68.5B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.96B 2.26B 289M 253M 234M 215M 406M 27.85B 412M 2.8B 1.1B 13.62B 1.08B 1.06B 46.94B EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.02x
Free-Float
28.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.43%
1 week-2.90%
Current month+5.98%
1 month+2.09%
3 months+6.27%
6 months-16.55%
Current year-23.23%
1 week 22.64
Extreme 22.64
25
1 month 20.24
Extreme 20.24
25
Current year 19
Extreme 19
30.46
1 year 19
Extreme 19
41.72
3 years 19
Extreme 19
41.72
5 years 19
Extreme 19
41.72
10 years 19
Extreme 19
41.72
Manager TitleAgeSince
Chief Executive Officer 58 2020-06-10
Director of Finance/CFO 53 2020-09-30
Investor Relations Contact 50 2023-08-31
Director TitleAgeSince
Chairman 58 2020-06-10
Director/Board Member 51 2022-01-26
Director/Board Member 63 2022-01-26
Date Insider Type Main position Quantity % Market Cap.
3/9/26 Other

Chief Executive Officer

68,201,112 48.0967%
3/9/26 Other

Director

68,201,112 48.0967%
3/9/26 Other

Director

68,201,112 48.0967%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-2.90%-30.56% - 418M
-0.49%-4.01%-0.84%+2.28% 49.18B
-3.10%-1.94%+370.99%+572.60% 39.58B
-0.46%+2.18%+5.44%+61.01% 34.69B
-1.14%-1.76%+26.94%-9.93% 34.42B
-1.82%-1.43%+0.52%+31.85% 27.11B
-3.54%-5.08% - - 16.21B
-1.82%-0.43%+69.28%+113.82% 15.36B
+1.17%+2.30%+15.87%+18.26% 14.05B
-2.25%+0.05%+15.77%-32.83% 13.02B
Average -1.30%-1.06%+52.60%+94.63% 24.4B
Weighted average by Cap. -1.43%-1.02%+75.72%+118.68%

Financials

2026 *2027 *
Net sales 684M 792M 101M 88.55M 81.85M 75.28M 142M 9.74B 144M 979M 384M 4.77B 379M 371M 16.42B 876M 1.01B 129M 113M 105M 96.36M 182M 12.47B 185M 1.25B 491M 6.1B 486M 475M 21.02B
Net income - -
Net Debt -898M -1.04B -133M -116M -107M -98.83M -186M -12.79B -189M -1.28B -504M -6.26B -498M -487M -21.56B -1.08B -1.25B -160M -140M -129M -119M -224M -15.39B -228M -1.55B -606M -7.53B -599M -586M -25.95B
Logo Medtide Inc.
Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.
Employees
566
Date Price Change Volume
26-07-20 HK$23.40 +0.43% 22,100
26-07-20 HK$23.30 +0.87% 100,300
26-07-17 HK$23.10 -3.43% 76,600
26-07-16 HK$23.92 -1.97% 115,300
26-07-15 HK$24.40 +1.24% 108,000
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
20.12CNY
Average target price
25.19CNY
Spread / Average Target
+25.19%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3880 Stock